Status:
COMPLETED
Tolerability of Grazax-R in Children
Lead Sponsor:
ALK-Abelló A/S
Conditions:
Allergy
Eligibility:
All Genders
5-12 years
Phase:
PHASE1
Brief Summary
This trial is performed to assess whether the Grazax-R treatment is safe to use in children aged 5-12 years.
Eligibility Criteria
Inclusion
- Grass pollen induced rhinoconjunctivitis
- Boys and girls, 5-12 years of age
- Positive skin prick test to grass pollen
Exclusion
- Previous treatment with immunotherapy
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00298701
Start Date
February 1 2006
End Date
April 1 2006
Last Update
May 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tangstedter Landstrasse 77
Hamburg, Germany, 22415